RxDoctor Payments Data

Alexander Hubb, MD

Urogynecology and Reconstructive Pelvic Surgery · Carmel, INNPI 1548674971

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.1% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Boston Scientific at 48.1% of the total. Reporting peaked in 2023 at $476 and has fallen 70.8% since, to $139 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in IN, where the typical reported total is $5,227.

$1,788in general payments, 2019–2025

Across 32 payments — averaging $55.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$860
  • Medtronic$668
  • Axonics, Inc.$173
  • Acera Surgical, Inc.$40
  • AbbVie$32
  • Intuitive Surgical$15

What the payments were for

  • Grants$1247%
  • Food & beverage$1,66493%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,788 in reported general payments places this provider in the 20th percentile of 21 urogynecology and reconstructive pelvic surgery providers in Indiana.

See all urogynecology and reconstructive pelvic surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$101,772
Medicare patients
136
Services billed
1,265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron78$47,988
GemtesaVibegron49$37,075
Mirabegron ErMirabegron21$10,129
Estradiol63$3,187
Trospium Chloride82$2,549
Methenamine Hippurate20$1,339
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst82$1,285
Solifenacin Succinate35$850
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim41$125
Fluconazole11$44
Oxycodone Hcl11$32

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →